Filed before 2025Filed 31 January 2012
Stemgent, Inc. raised $6.3M
Stemgent, Inc., a biotech company based in Cambridge, MA, raised $6.3M in a new equity round, according to a filing dated 31 January 2012.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 31 January 2012
- Round
- Equity round
- Amount sold
- $6.3M
- Offering size
- $8.8M
- Investors so far
- 8
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 63% of the 368 tracked raises with an amount filed in 2012, and than 69% of the 32 in biotech.
Stemgent, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 31 Jan 2012 | New filing | $6.3M | This raise |
More with Lightstone Ventures on the board
- Imperative Care, Inc.$111M
- Apreo Health, Inc.$81.8M
- Allay Therapeutics, Inc.$45M
- Cala Health, Inc.$48.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.